Trials / Completed
CompletedNCT06161363
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus in a Hospital Internal Medicine Consultation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them. The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | The Morisky Medication Adherence Scale | The Morisky Medication Adherence Scale will be completed bu the patients |
Timeline
- Start date
- 2023-11-27
- Primary completion
- 2024-11-16
- Completion
- 2024-12-16
- First posted
- 2023-12-07
- Last updated
- 2025-12-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06161363. Inclusion in this directory is not an endorsement.